Nuromol
){kind=logo}
- Nuromol contains ibuprofen 200mg and paracetamol 500mg¹
- Nuromol provides powerful, opioid-free pain relief
- Every patient we save from potential opioid dependence is a WIN. Opioid dependence can happen as little as 2-10 days with continuous use²
- If we can help relieve acute pain, but spare the opioids, that's a WIN. Effective, non-opioid alternatives for acute moderate pain relief may help mitigate opioid dependence before it starts³
- A non-addictive alternative for powerful pain relief is a WIN. Nuromol provides pain relief as affective as co-codamol⁴, and is not known to cause addiction¹
Recommended Dosage
- Take 1 tablet up to 3 times a day with water¹
- Do not exceed 6 tablets in 24 hours and leave 6 hours between doses¹
- Do not give to children under 18 years¹
REFERENCES:
- NUROMOL Summary of Product Characteristics. Last accessed December 2024. Available at: https://www.medicines.org.uk/emc/product/13804/smpc.
- NICE, CKS. Opioid dependence: what is it? Last accessed December 2024. Available at: https://cks.nice.org.uk/topics/opioid-dependence/background-information/definition/.
- Kinnaird E et al. BMJ Open 2019;9:e025331
- Daniels S et al. Pain 2011;152:632-642
ESSENTIAL INFORMATION:
Nuromol Pain Relief 200 mg/500 mg film coated tablets (200mg ibuprofen and 500mg paracetamol). For the temporary relief of mild to moderate pain associated with migraine, headache, backache, period pain, dental pain, rheumatic and muscular pain, pain of non-serious arthritis, cold and flu symptoms, sore throat and fever. This product is especially suitable for pain which has not been relieved by ibuprofen or paracetamol alone (400mg ibuprofen, 1000mg paracetamol). Nuromol Pain Relief 200mg/500mg Film Coated Tablets is indicated in adults aged 18 years. Licence Holder: Reckitt Benckiser Healthcare (UK) Limited, Slough, SL1 3UH. MRRP: 24’s £6.99 & 32s £8.60. Legal Classification: P. Information about this product, including adverse reactions, precautions, contraindications, and method of use can be found at https://www.medicines.org.uk/emc/product/13804/smpc Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for the MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Reckitt Benckiser Healthcare (UK) Ltd on: 0333 200 5345
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
.png/fit-in/500x500/filters:no_upscale())
)
)
)
)
)
)
)
)
)
)
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
)
)
.png/fit-in/1280x9999/filters:no_upscale()){kind=logo}
)
)
)
)
)
)
){kind=logo}
